Načítá se...

P17.93 THIRD LINE CHEMOTHERAPY IN HIGH GRADE GLIOMAS: THERE IS A BENEFIT?

BACKGROUND: Advances in surgical approaches, radiotherapy, and chemotherapy are contributing to incremental improvements in survival of the patients with High Grade Gliomas (HGG) but few options exist for the management of recurrent or resistant disease. Long survivors are often treated with more li...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Villani, V., Fabi, A., Terrenato, I., Telera, S., Marucci, L., Carosi, M., Vidiri, A., Carapella, C.M., Pace, A.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2014
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185797/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.422
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!